SK-Hep1 인체 간암 세포에서 Luteolin에 의한 TRAIL 저항성 감소 효과
Sensitization of TRAIL-resistant SK-Hep1 Human Hepatocellular Carcinoma Cells by Luteolin
  • 김은영
  • 김안근
Citations

WEB OF SCIENCE

0
Citations

SCOPUS

0

초록

In this study, we examined the effect of luteolin to enhance TRAIL-induced anticancer effect in SK-Hep1 cells. We found that combined use of TRAIL with luteolin markedly enhanced the cytotoxicity compared to either agent alone by inducing apoptosis. Furthermore, combined treatment of TRAIL with luteolin significantly induced activation of death receptor pathway-related proteins as well as PARP-cleavage and activation of effector caspases. Also, our result indicated that upregulation of DR4 and DR5 by luteolin combination may contribute to enhanced susceptibility of SK-Hep1 cells to TRAIL.

키워드

TRAILluteolinapoptosisdeath receptors
제목
SK-Hep1 인체 간암 세포에서 Luteolin에 의한 TRAIL 저항성 감소 효과
제목 (타언어)
Sensitization of TRAIL-resistant SK-Hep1 Human Hepatocellular Carcinoma Cells by Luteolin
저자
김은영김안근
발행일
2012-02
저널명
약 학 회 지
56
1
페이지
35 ~ 41